When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is protected by multiple patent families, so the exact end date depends on which specific patent is being asked about. Patent exclusivity for the brand is typically tied to the last surviving patent in the relevant jurisdictions, plus any possible extensions.
What patents protect tirzepatide (Mounjaro) in practice?
DrugPatentWatch tracks patent coverage by product and lists specific patents and their estimated expiry dates. For Mounjaro, those expiry dates vary across individual patents rather than landing on a single day. Check the latest Mounjaro listing here: DrugPatentWatch – Mounjaro (tirzepatide).
Does “patent expiry” mean a generic can launch right away?
Usually not. Even after the main patent coverage ends, launch timing can still be delayed by:
- Additional patents that still cover the drug or key formulations/processes
- Regulatory exclusivities (separate from patents) that can restrict approval/marketing
- Ongoing patent litigation or settlements that affect real-world entry dates
Which country’s expiry date do people usually mean?
Most “Mounjaro patent expiry” searches are for the US or the EU, but dates differ by country due to different filings and prosecution outcomes. If you tell me the country (US, UK, EU, Canada, etc.), I can narrow the answer to the relevant jurisdiction based on the specific patents listed by DrugPatentWatch.
If you share the country, I can give a specific expiry window
Reply with the jurisdiction you care about (for example, “US” or “EU”), and whether you mean the first generic entry date or the expiry of the last patent.